Gregory L. Gerdeman, PhD - Publications

Affiliations: 
Biology Eckerd College, Saint Petersburg, FL, United States 
Area:
neuropharmacology, cannabinoids

6/11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2008 Gerdeman GL. Endocannabinoids at the synapse: Retrograde signaling and presynaptic plasticity in the brain Cannabinoids and the Brain. 203-236. DOI: 10.1007/978-0-387-74349-3_11  0.438
2004 Ronesi J, Gerdeman GL, Lovinger DM. Disruption of endocannabinoid release and striatal long-term depression by postsynaptic blockade of endocannabinoid membrane transport. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 1673-9. PMID 14973237 DOI: 10.1523/Jneurosci.5214-03.2004  0.639
2003 Gerdeman GL, Lovinger DM. Emerging roles for endocannabinoids in long-term synaptic plasticity. British Journal of Pharmacology. 140: 781-9. PMID 14504143 DOI: 10.1038/Sj.Bjp.0705466  0.672
2003 Gerdeman GL, Partridge JG, Lupica CR, Lovinger DM. It could be habit forming: drugs of abuse and striatal synaptic plasticity. Trends in Neurosciences. 26: 184-92. PMID 12689769 DOI: 10.1016/S0166-2236(03)00065-1  0.611
2002 Gerdeman GL, Ronesi J, Lovinger DM. Postsynaptic endocannabinoid release is critical to long-term depression in the striatum. Nature Neuroscience. 5: 446-51. PMID 11976704 DOI: 10.1038/Nn832  0.643
2001 Gerdeman G, Lovinger DM. CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum. Journal of Neurophysiology. 85: 468-71. PMID 11152748 DOI: 10.1152/Jn.2001.85.1.468  0.651
Low-probability matches (unlikely to be authored by this person)
2008 Gerdeman GL, Schechter JB, French ED. Context-specific reversal of cocaine sensitization by the CB1 cannabinoid receptor antagonist rimonabant. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 2747-59. PMID 18059436 DOI: 10.1038/Sj.Npp.1301648  0.297
2012 Raichlen DA, Foster AD, Gerdeman GL, Seillier A, Giuffrida A. Wired to run: exercise-induced endocannabinoid signaling in humans and cursorial mammals with implications for the 'runner's high'. The Journal of Experimental Biology. 215: 1331-6. PMID 22442371 DOI: 10.1242/Jeb.063677  0.273
2008 Keeney BK, Raichlen DA, Meek TH, Wijeratne RS, Middleton KM, Gerdeman GL, Garland T. Differential response to a selective cannabinoid receptor antagonist (SR141716: rimonabant) in female mice from lines selectively bred for high voluntary wheel-running behaviour. Behavioural Pharmacology. 19: 812-20. PMID 19020416 DOI: 10.1097/Fbp.0B013E32831C3B6B  0.264
2013 Raichlen DA, Foster AD, Seillier A, Giuffrida A, Gerdeman GL. Exercise-induced endocannabinoid signaling is modulated by intensity. European Journal of Applied Physiology. 113: 869-75. PMID 22990628 DOI: 10.1007/S00421-012-2495-5  0.24
2008 Gerdeman GL, Fernández-Ruiz J. The endocannabinoid system in the physiology and pathology of the basal ganglia Cannabinoids and the Brain. 423-483. DOI: 10.1007/978-0-387-74349-3_21  0.103
Hide low-probability matches.